Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days

Volume: 27, Issue: 11, Pages: 4211 - 4218
Published: Aug 21, 2012
Abstract
BackgroundEnd-stage renal failure (ESRF) patients demonstrate augmented growth hormone (GH) secretion, but normal insulin-like growth factor-I (IGF-I) concentrations, indicating a state of GH resistance. To test this hypothesis, we compared the IGF-I response with exogenous GH in haemodialysis patients and healthy controls, with special focus on free GH and bioactive...
Paper Details
Title
Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days
Published Date
Aug 21, 2012
Volume
27
Issue
11
Pages
4211 - 4218
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.